Immunologic therapy for ARDS, septic shock, and multiple-organ failure
- PMID: 8449096
- DOI: 10.1378/chest.103.3.932
Immunologic therapy for ARDS, septic shock, and multiple-organ failure
Abstract
Advances in cytokine biology and molecular biology have led to the development of novel immunologic approaches to the treatment of septic shock, ARDS, and MOF. These advances are necessary since improvements in supportive care clearly fall short of the hoped-for reductions in mortality associated with these disorders. As noted in this review, these new therapies are directed at three distinct levels of the inflammatory cascade: (1) the inciting event or insult (eg, endotoxin); (2) the mediators (eg, TNF, IL-1); and (3) the effector cells (eg, neutrophils). The current status of these treatments has been reviewed; and while each individual therapy has shown potential, it is likely that combinations of these agents may be necessary to substantially impact on survival. That is, due to the complexity and redundancy of the inflammatory network, it is doubtful that a "magic bullet" will be found. However, it is also clear that advances in our understanding of the pathogenesis of ARDS, septic shock, and MOF at the molecular level have provided clinicians with powerful weapons with which to do battle. It remains to be seen which ones will work the best.
Similar articles
-
Anti-inflammatory therapies: application of molecular biology techniques in intensive care medicine.Intensive Care Med. 1997 Jul;23(7):718-31. doi: 10.1007/s001340050400. Intensive Care Med. 1997. PMID: 9290984 Free PMC article. Review. No abstract available.
-
Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators.Br J Surg. 1992 Oct;79(10):998-1003. doi: 10.1002/bjs.1800791006. Br J Surg. 1992. PMID: 1422741 Review.
-
Host responses in mediating sepsis and adult respiratory distress syndrome.Semin Respir Infect. 1990 Sep;5(3):233-47. Semin Respir Infect. 1990. PMID: 2123991 Review.
-
New treatments for sepsis.Crit Care Med. 1993 Sep;21(9 Suppl):S310-4. doi: 10.1097/00003246-199309001-00003. Crit Care Med. 1993. PMID: 8365201 Review. No abstract available.
-
Current understanding of the pathogenesis of gram-negative shock.Infect Dis Clin North Am. 1991 Dec;5(4):781-91. Infect Dis Clin North Am. 1991. PMID: 1783767 Review.
Cited by
-
Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.Infection. 1994 May-Jun;22(3):160-4. doi: 10.1007/BF01716695. Infection. 1994. PMID: 7927810
-
Intrapulmonary Hartmannella vermiformis: a potential niche for Legionella pneumophila replication in a murine model of legionellosis.Infect Immun. 1997 Nov;65(11):4892-6. doi: 10.1128/iai.65.11.4892-4896.1997. Infect Immun. 1997. PMID: 9353084 Free PMC article.
-
Role of Kupffer cells in acute hemorrhagic necrotizing pancreatitis-associated lung injury of rats.World J Gastroenterol. 2006 Jan 21;12(3):403-7. doi: 10.3748/wjg.v12.i3.403. World J Gastroenterol. 2006. PMID: 16489639 Free PMC article.
-
Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.Semin Immunopathol. 2012 Mar;34(2):299-315. doi: 10.1007/s00281-011-0297-1. Epub 2011 Nov 17. Semin Immunopathol. 2012. PMID: 22089960 Review.
-
Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient.J Thorac Dis. 2016 Jun;8(6):E424-30. doi: 10.21037/jtd.2016.04.37. J Thorac Dis. 2016. PMID: 27293871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials